1. Acitretin systemk and retinoic acid 0.1% cream supression of basal cell carcinoma.
- Author
-
Xi-Bao Zhang, San-Quan Zhang, Chang-Xing Li, Zhen-Ming Huang, and Yu-Wu Luo
- Subjects
- *
RETINOIDS , *BASAL cell nevus syndrome , *XERODERMA pigmentosum , *T-cell lymphoma , *BASAL cell carcinoma , *HISTOPATHOLOGY , *OLDER patients , *SURGERY , *CURETTAGE , *CRYOSURGERY , *PATIENTS , *THERAPEUTICS - Abstract
Retinoids have been used for years as monotherapy and/or in combination for treatment and suppression of cutaneous malignancies in patients with basal cell nevus syndrome, xeroderma pigmentosum, or cutaneous T-cell lymphoma (CTCL) basal cell carcinoma (BCC). We report 4 cases with BCC confirmed by histopathology who were treated by shortterm systemic acitretin combined with retinoic acid 0.1% cream. The 4 cases with BCC showed good response to the treatment without severe adverse effects during treatment and follow-up. The finding suggests that acitretin may be an appropriate treatment option for elderly patients who require less invasive treatment for BCC. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF